首页> 外文期刊>Biophysical Journal >Allostery in Coagulation Factor VIIa Revealed by Ensemble Refinement of Crystallographic Structures
【24h】

Allostery in Coagulation Factor VIIa Revealed by Ensemble Refinement of Crystallographic Structures

机译:凝血因子viia的古代植物揭示了晶体结构的精细化

获取原文
获取原文并翻译 | 示例
           

摘要

A critical step in injury-induced initiation of blood coagulation is the formation of the complex between the trypsin-like protease coagulation factor VIIa (FVIIa) and its cofactor tissue factor (TF), which converts FVIIa from an intrinsically poor enzyme to an active protease capable of activating zymogens of downstream coagulation proteases. Unlike its constitutively active ancestor trypsin, FVIIa is allosterically activated (by TF). Here, ensemble refinement of crystallographic structures, which uses multiple copies of the entire structure as a means of representing structural flexibility, is applied to explore the impacts of inhibitor binding to trypsin and FVIIa, as well as cofactor binding to FVIIa. To assess the conformational flexibility and its role in allosteric pathways in these proteases, main-chain hydrogen bond networks are analyzed by calculating the hydrogen-bond propensity. Mapping pairwise propensity differences between relevant structures shows that binding of the inhibitor benzamidine to trypsin has a minor influence on the protease flexibility. For FVIIa, in contrast, the protease domain is "locked'' into the catalytically competent trypsin-like configuration upon benzamidine binding as indicated by the stabilization of key structural features: the nonprime binding cleft and the oxyanion hole are stabilized, and the effect propagates from the active site region to the calcium-binding site and to the vicinity of the disulphide bridge connecting with the light chain. TF binding to FVIIa furthermore results in stabilization of the 170 loop, which in turn propagates an allosteric signal from the TF-binding region to the active site. Analyses of disulphide bridge energy and flexibility reflect the striking stability difference between the unregulated enzyme and the allosterically activated form after inhibitor or cofactor binding. The ensemble refinement analyses show directly, for the first time to our knowledge, whole-domain structural footprints of TF-induced allosteric networks present in x-ray crystallographic structures of FVIIa, which previously only have been hypothesized or indirectly inferred.
机译:血液凝固的损伤引发的关键步骤是胰蛋白酶样蛋白酶凝血因子VIIA(FVIIA)与其辅助因子组织因子(TF)之间的复合物形成,其将FVIIA从内在较差的酶转化为活性蛋白酶能够激活下游凝血蛋白酶的雌激素。与其组成型活跃的祖先胰蛋白酶不同,FVIIA是体上激活的(通过TF)。这里,使用整个结构的多个副本作为代表结构柔韧性的方法的结晶结构的集合细化,用于探讨抑制剂结合到胰蛋白酶和FVIIA的影响,以及与FVIIA结合的辅因子。为了评估这些蛋白酶的构象途径中的构象灵活性及其作用,通过计算氢键倾向来分析主链氢键网络。测绘的成对倾向差异相关结构之间的差异表明抑制剂苯胺酰胺与胰蛋白酶的结合对蛋白酶柔性的微小影响。相反,对于FVIIA,蛋白酶结构域在苯胺结合时“锁定”在催化竞技胰蛋白酶样结构中,如关键结构特征的稳定化所示:非掺杂结合和氧气孔稳定,并且效果繁殖从活性部位区域到钙结合位点以及与轻链连接的二硫桥附近。TF与FVIIa结合,此外导致170环的稳定,这又传播来自TF结合的变构信号区域到活性位点。分析二硫化物桥能量和灵活性反映了抑制剂或辅因子结合后的未调节酶和变色活化的形式之间的醒目稳定性差异。集合改进分析直接显示,首次向我们的知识,全部显示F的X射线晶体结构存在于F的TF诱导变构网络的结构域结构足迹viia,此前仅被假设或间接推断出来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号